November 21, 2025 04:18 PM GMT China Healthcare | Asia Pacific Catalysts Preview for Leading CDMOs China's CDMOs should continue to benefit from robust biopharma out-licensing activity and recovery of early-stage financing. We identify potential, time-specific, catalysts for each of the WuXis in the next six months. Morgan Stanley Asia Limited ("Morgan Stanley") is acting as the financial advisor to an affiliate of Wuxi Apptec Co., Ltd ("Wuxi Apptec") in relation to the proposed acquisition of its site mana ...